Related content

Treatment of Febrile Neutropenia Is Expensive: Prevention Is the Answer

By  

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 226-228

Karger

Access to resources Recommend Favorite

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

By Cherif Honar   Björkholm Magnus   Engervall Per   Johansson Peter   Ljungman Per   Hast Robert   Kalin Mats  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 8, 2004-08 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Cefepime and Ceftazidime in Combination with Amikacin in the Empirical Treatment of High-risk Patients with Febrile Neutropenia: A Prospective, Randomized, Multicenter Study

By Erman Mustafa   Akova Murat   Akan Hamdi   Korten Volkan   Ferhanoğlu Burhan   Köksal Iftihar   Çetinkaya Yeşim   Uzun Ömrüm   Ünal Serhat  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite

Use of Inflammatory Markers for Early Detection of Bacteraemia in Patients with Febrile Neutropenia

By Persson Lennart   Engervall Per   Magnuson Anders   Vikerfors Tomas   Söderquist Bo   Hansson Lars-olof   Tidefelt Ulf  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 5, 2004-05 ,pp. : 365-371

Informa Healthcare

Access to resources Recommend Favorite

Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain

By Mayordomo José Ignacio   López Andrés   Viñolas Núria   Castellanos Javier   Pernas Sonia   Domingo Alonso Juan   Frau Adolfo   Layola Miquel   Antonio Gasquet José   Sánchez Jordi  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2533-2542

Informa Healthcare

Access to resources Recommend Favorite